SCINUS Webinar on ‘Upscaling: Optimize your cell therapy process for production in a bioreactor’
Are you working on a promising cell therapeutic product? Very well! But have you considered adapting your cell therapy process for an upscaled production? Larger dosages are certainly needed when you move into clinical trials and even further towards market authorization. It is key to initiate this optimization step early in your development as changes […]
On-line roundtable on ‘ATMP logistic challenges’
Join us for an interesting roundtable on ‘ATMP logistic challenges’, in collaboration with VIL, Flanders innovation cluster for Logistics, and moderated by Inovigate. When? October 8th, from 11 am till 12.15 pm. Where? This is an on-line roundtable. You will receive the link for participation upon registration. What is it about? The market for cell and […]
Meet Yanick Fanton, Lab Director at Beta-Cell N.V.
The Covid-19 lockdown prevented us to organize a ‘real life’ network meeting to bring our at.las members together. Luckily, it didn’t prevent us to find new ways of getting to know each other. During a zoom-meeting, we had a nice talk with Yanick Fanton, Lab Director at Beta-Cell N.V. In this interview, she introduces Beta-Cell and talks about the […]
TRIUM training on ‘Good Clinical Practice’
Join us for this exciting on-line training on ‘Good Clinical Practices’ or GCP, organized by the at.las member TRIUM. The training will take place on June 30th, from 3 pm till 5 pm. And yes, it is FREE!!! What is the training about? For the novice research professional, the clinical research field can seem both […]
The ReSToRe project: a cell therapy for MS from UZA/UAntwerpen
On May 30th 2020, it was international MS day. MS is a brain and spinal cord disease, affecting approximately 1 in 1.000 people in Europe. UZA and Uantwerpen, 2 members of our network, joined forces with scientists in Spain, The Netherlands and Germany to develop a novel antigen specific cell therapy for MS patients. This […]
ISCT Conference, Paris
THIS CONFERENCE IS HELD VIRTUALLY DUE TO COVID-19 OUTBREAK On 28-29 May 2020, more than 2000 global experts will discuss remotely during the ISCT annual meeting to ‘Accelerate Cell and Gene Therapy Adoption: From Proof of Concept to Standard of Care’. More info on the program and about registrations can be found here.
Meeting on the Med, Barcelona
CANCELLED DUE TO COVID-19 OUTBREAK. The Cell & Gene Meeting on the Mediterranean is the leading conference that brings together the entire cell and gene therapy community from Europe and beyond. The conference covers a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector. It features expert-led […]